BioWorld MedTech

May 18, 2012

EuroPCR 2012: Unnerving developments in renal denervation: Product pipeline packed as competition heats up

PARIS While cardiologists play coy about their interest in taking up the new procedure for renal denervation, industry is running at full steam toward what can only be described a massive market opportunity. Read More

GE, Philips take center stage in FCC MBANs discussion

Cardiologists conflicted over role in kidney intervention

Washington roundup: Speaker proposes cost as a criterion for trial coverage

Deals roundup: CryoLife completes Hemosphere acquisition for more than $17M

Financings roundup: Zyga Technology raises $25M in a Series C funding round

Court report: Medtronic claims government has closed Infuse investigation

EuroPCR notebook: Medtronic study: CoreValve benefits men, women similarly

Agreements/contracts: 3M to open healthcare dictionary to DoD, VA

Product Briefs

People in the News

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for Nov. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for November 27, 2024.

Illustration of man holding magnifying glass to human body model showing muscle anatomy

In muscular dystrophies, gene therapies race the clock

BioWorld

Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...

AI-generated illustration of heart and metabolic impact

Bridgebio, with FDA approval, faces Pfizer in ATTR

BioWorld

With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...

‘Evo’ AI can design complete genomes

BioWorld Science

The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...